Predictions
ImmunityBio Inc.
Start price
Target price
Perf. (%)
€2.30
29.10.23
29.10.23
€4.00
30.06.26
30.06.26
247.39%
29.04.24
29.04.24
Could be very worthwhile Investment >20% year
Inotiv Inc.
Start price
Target price
Perf. (%)
€5.50
13.04.24
13.04.24
€4.00
13.04.25
13.04.25
-32.36%
27.04.24
27.04.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.51
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
-0.66%
27.04.24
27.04.24
negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€56.40
20.04.23
20.04.23
€60.11
20.04.24
20.04.24
22.34%
21.04.24
21.04.24
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€87.00
17.04.23
17.04.23
€95.00
17.04.24
17.04.24
87.36%
18.04.24
18.04.24
Alpine Immune Sciences Inc
Start price
Target price
Perf. (%)
€11.50
22.07.23
22.07.23
€15.00
31.08.26
31.08.26
430.43%
12.04.24
12.04.24
Could be very worthwhile Investment >20% year
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€103.40
11.04.23
11.04.23
€113.61
11.04.24
11.04.24
13.73%
12.04.24
12.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€34.60
03.04.23
03.04.23
€56.02
03.04.24
03.04.24
87.86%
04.04.24
04.04.24
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€32.60
31.03.23
31.03.23
€45.16
31.03.24
31.03.24
110.12%
01.04.24
01.04.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€89.90
30.03.23
30.03.23
€120.95
30.03.24
30.03.24
47.22%
01.04.24
01.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€60.85
29.03.24
29.03.24
22.14%
30.03.24
30.03.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€52.40
29.03.23
29.03.23
€58.10
29.03.24
29.03.24
22.14%
30.03.24
30.03.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€736.80
23.03.23
23.03.23
€791.57
23.03.24
23.03.24
20.86%
24.03.24
24.03.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€307.70
13.03.23
13.03.23
€350.10
13.03.24
13.03.24
124.73%
14.03.24
14.03.24
Invitae Corp
Start price
Target price
Perf. (%)
€1.30
11.03.23
11.03.23
€0.40
11.03.24
11.03.24
-93.65%
12.03.24
12.03.24
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€41.80
09.03.23
09.03.23
€54.81
09.03.24
09.03.24
45.22%
10.03.24
10.03.24